Skip to content
ppharmaranks
Menu

IZBA vs LATISSE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. IZBA and LATISSE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
72/100

Pharmacy pays

$9.56 /mL
$7.87 /mL

Type

RX
RX

Active ingredient

TRAVOPROST
BIMATOPROST

Manufacturer

Dosage forms

Drops
Drops

Drug class

Prostaglandin Analog
Prostaglandin Analog

Boxed warning

None
None

Treats

Open-Angle Glaucoma
Open-Angle Glaucoma

Frequently asked questions

Which is better-rated, Izba or Latisse?

By our independent rating, Latisse scores higher — 3.6 vs 3.5 out of 5 for Izba. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Izba or Latisse?

Latisse costs pharmacies less to acquire — about $7.87 vs $9.56 per ml, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Izba and Latisse?

Izba contains Travoprost, while Latisse contains Bimatoprost — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.